Kazuhiro Chiba
Corporate Officer/Principal chez Tokyo University of Agriculture & Technology
Profil
Kazuhiro Chiba founded Jitsubo Co., Ltd.
in 2005, where he worked as Director & Chief Scientific Officer.
Dr. Chiba also currently works at Tokyo University of Agriculture & Technology, as Vice Dean & Professor.
Dr. Chiba also formerly worked at Kewpie Corp., as Principal.
Dr. Chiba received his graduate degree from Tokyo University of Agriculture & Technology.
Postes actifs de Kazuhiro Chiba
| Sociétés | Poste | Début |
|---|---|---|
| Tokyo University of Agriculture & Technology | Corporate Officer/Principal | - |
Anciens postes connus de Kazuhiro Chiba
| Sociétés | Poste | Fin |
|---|---|---|
| KEWPIE CORPORATION | Corporate Officer/Principal | - |
Jitsubo Co., Ltd.
 Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Fondateur | - |
Formation de Kazuhiro Chiba
| Tokyo University of Agriculture & Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KEWPIE CORPORATION | Consumer Non-Durables |
| Entreprise privées | 1 |
|---|---|
Jitsubo Co., Ltd.
Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Health Technology |
